241 related articles for article (PubMed ID: 15925224)
1. Pharmacokinetics of radiolabelled quinlukast in rats.
Syrovatko M; Laznickova A; Laznicek M
J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
[TBL] [Abstract][Full Text] [Related]
2. HPLC-radiometric determination of quinlukast in biological fluids.
Syrovatko M; Laznickova A; Laznicek M; Wsol V
J Pharm Biomed Anal; 2004 Apr; 35(1):177-83. PubMed ID: 15030892
[TBL] [Abstract][Full Text] [Related]
3. alpha-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused liver.
te Koppele JM; Dogterom P; Vermeulen NP; Meijer DK; van der Gen A; Mulder GJ
J Pharmacol Exp Ther; 1986 Dec; 239(3):905-14. PubMed ID: 3795049
[TBL] [Abstract][Full Text] [Related]
4. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
5. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
Ray GF; Mason WD; Badr MZ
Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.
Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK
Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177
[TBL] [Abstract][Full Text] [Related]
8. Disposition of the opioid antagonist, LY255582, in rats and dogs.
Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
[TBL] [Abstract][Full Text] [Related]
9. Disposition, metabolism, and excretion of U-71038, a novel renin inhibitor peptide, in the rat.
Greenfield JC; Cook KJ; O'Leary IA
Drug Metab Dispos; 1989; 17(5):518-25. PubMed ID: 2573495
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of [3H]levamisole in pigs after oral and intramuscular administration.
Galtier P; Escoula L; Alvinerie M
Am J Vet Res; 1983 Apr; 44(4):583-7. PubMed ID: 6869955
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.
Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR
Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052
[TBL] [Abstract][Full Text] [Related]
14. Effect of its demethylated metabolite on the pharmacokinetics of unchanged TAK-603, a new antirheumatic agent, in rats.
Tagawa Y; Miwa K; Tsukuda R; Yoshimura Y; Tanayama S; Tanigawara Y
Drug Metab Dispos; 1999 Apr; 27(4):495-501. PubMed ID: 10101145
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive analysis of the anti-tumor agent 1-[4-(furo[2,3-b]-quinolin-4-ylamino)phenyl]ethanone in rat plasma by high-performance liquid chromatography using electrochemical detection.
Huang YB; Wu PC; Hsu MW; Chen YL; Tzeng CC; Tsai YH
J Pharm Biomed Anal; 2005 Jul; 38(3):551-5. PubMed ID: 15925259
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
Egfjord M
Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of digoxin in the rat.
Harrison LI; Gibaldi M
Drug Metab Dispos; 1976; 4(1):88-93. PubMed ID: 3407
[TBL] [Abstract][Full Text] [Related]
18. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Walder P; Buchar E; Machková Z; Vrba T; Flegel M; Janků I; Masek K
Immunopharmacol Immunotoxicol; 1991; 13(1-2):101-19. PubMed ID: 1770213
[TBL] [Abstract][Full Text] [Related]
20. Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes.
Cox JW; Dring LG; Ginsberg LC; Larson PG; Constable DA; Ulrich RG
Drug Metab Dispos; 1990; 18(5):726-31. PubMed ID: 1981727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
